May 30, 2012
Shionogi & Co. launched OxiFast Injection 10 mg and 50 mg (oxycodone hydrochloride hydrate) for the treatment of cancer pain on May 28. While the company has already been marketing an oral medication of the same active pharmaceutical ingredient (API),...read more